The Russian T-15 infantry fighting vehicle represents an attempt to combine main battle tank-level protection with troop transport capability. Built on the Armata platform, its design prioritizes crew ...

If successful, Armata would become the first bacteriophage company to advance a clinical candidate through Phase 3 testing, potentially introducing a new treatment option for patients with complicated ...

The Suzuki Jimny has become something of a cult canvas for tuners, with countless conversions building on its boxy shape and straightforward design. Unsurprisingly, the five-door version has followed ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Shares of Armata Pharmaceuticals (NYSE:ARMP) climbed nearly 300% on Wednesday after the Los Angeles-based biotech posted data from a mid-stage trial for its antibacterial agent AP-SA02 targeting ...

Dr. Loren G. Miller, M.D., M.P.H., Professor of Medicine, David Geffen School of Medicine at UCLA, Chief, Division of Infectious Diseases at Harbor-UCLA Medical Center and the Lundquist Institute The ...

LOS ANGELES, Sept. 8, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of ...

- GAAP revenue was $2.2 million, outpacing the $1.38 million GAAP consensus estimate due to strong grant and award funding. - Net loss widened significantly to $0.45 per share (GAAP). - Armata ...

Jake is a writer from the United Kingdom. With a focus on first-person shooters, RPGs, and achievement hunting, writing about the gaming industry comes naturally and is a real point of pride. Outside ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage cocktail to improved outcomes in patients with bacteria in their blood, opening ...